Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2Phase 1 2Phase 3 1

Status

Unknown 2Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Gynecologic Cancer 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 51fludarabine 38Injections 32Gemcitabine 25Paclitaxel 24Cisplatin 22Radiotherapy 19toripalimab 18pembrolizumab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 14Nivolumab 14Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Immunotherapy, Adoptive 11Cetuximab 11Bevacizumab 10Irinotecan 9Drug Therapy 9sintilimab 8Etoposide 8aldesleukin 7Taxes 7Rituximab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Population Groups × Clear all
NCT05352646 2023-09-28

NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection

Newish Technology (Beijing) Co., Ltd.

Phase 1 Unknown
26 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01304745 2013-07-09

Rehabilitation of Women Following Treatment for Gynaecological Cancer; a Randomized, Controlled Study

Haukeland University Hospital

Phase 1 Unknown
130 enrolled
Gynecologic

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡